Johnson & Johnson
JNJ · NYSE · USD · Healthcare
1What is happening
Johnson & Johnson has fallen 2% since its 6-week high on 30/10/2026. How it continues – phase and signs – you see with a free account.
Free account · 3 stocks and coins a dayfrom the 6-week high-2.1%
Other view · 22 analystsHorizon: 12 months16 Buy · 6 Hold · 1 Sell2Our assessment
No dip32How it continues – phase and signs – you see with a free account.
3Your next step
Marking places no order – it only helps you keep track.
More details · reasons, figures, alerts
How deep is the dip?
- from the 6-week high-2.1%
Highest daily price: $282.02 on 30/10/2026 · reference of the assessment · also the highest of the last 3 months
- from the 52-week high-2.1%
Highest price in 52 weeks: $282.02 (Yahoo)
What analysts expect
Most of the 22 analysts say buy. They look about 12 months ahead – DipCatcher only 14 trading days.
- Buy
- 1670 %
- Hold
- 626 %
- Sell
- 14 %
Average price target$279.41
$190.00 to $320.00 · today $276.22
$190.00Ø $279.41$320.00
What is a price target?
The price an analyst expects in about 12 months. Estimates are often far apart and change frequently.
Third-party opinion, not an assessment by DipCatcher. Source: public analyst estimates, as of 08/11/2026. Not financial advice.
Dates
- 24NovEx-dividendBuying from this day no longer gets the next dividend. The price usually drops by about the dividend.
- 8DecDividend paymentThe dividend is paid on this day.
- 26JanQuarterly resultsJohnson & Johnson reports results. Prices often move more around this date.
The company in figures
- Market value
- 664.9 bn $
- All shares together at the current price.
- P/E
- 41.9
- Price divided by earnings per share, last 12 months.
- Dividend yield
- 1.94 %
- Yearly dividend relative to the price.
- 52-week range
- $185.12 – $282.02
- Lowest and highest price of the last year.
Catalysts
42 h ago- News, last 10 days
- no recent news
- Next earnings
- 26/01/2027 · in 81 days
- Last report
- 13/10/2026 +2.7% vs estimate
Key figures
- Market value
- 664.9 bn $Large cap
- P/E
- 41.9
- Dividend yield
- 1.94 %
- Volume today
- 1.3 × Øabout usual
- Beta
- 0.20swings less than the market
- 52-week range
- $185.12 – $282.02price at 94 % of the range
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.
- Headquarters:
- New Brunswick, United States
- 52-week range:
- $185.12 – $282.02
- Website:
- jnj.com
Trade levels
Why the engine says so
History for this stock or coin
Watch and alert
See which stocks they are
The engine is watching these dips right now. A free account shows the names and opens 3 full analyses a day.
- 3 full analyses a dayWith entry, target, stop and the reasons behind them.
- WatchlistFollow the stocks you care about.
Free, no payment details.
Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search
Not investment advice. Investing carries risk up to total loss.